AsianScientist (Jun. 3, 2019) – Hong Kong-headquartered healthcare services provider Zuellig Pharma has acquired Singapore-based healthtech startup Klinify for an undisclosed amount.
Klinify is a cloud-based management system used by over 800 doctors in Malaysia to manage their clinics more efficiently. It allows doctors to migrate to electronic records using tablet computers without having to change their workflow process. Klinify was founded by Krish Surendran and Nishanth Sudharsanam, and was formerly known as Doctree.Asia.
“We are thrilled to be part of Zuellig Pharma’s broad network in Asia. The ability to integrate with their existing services allows doctors to get significantly more value out of Klinify as it will create a single portal for many of their clinic management needs,” said Surendran.
Zuellig Pharma had invested in Klinify earlier in May 2017 to support its regional expansion and product development. In the tie-up, Zuellig also integrated its services such as product ordering and inventory management into the application.
“Our goal is to use digital channels to complement our existing businesses and unite the healthcare ecosystem, leading to improved outcomes and lower cost of quality healthcare for patients in Asia,” said Benjamin Belot, Zuellig Pharma Head of Digital Investments and Partnerships.
Source: Zuellig Pharma; Photo: Shutterstock.
Disclaimer: This article does not necessarily reflect the views of AsianScientist or its staff.